International Journal of Molecular Sciences · 2020 · 37 citations · 40 references
MedicineCancer BiologyOncologyChemotherapyMolecular OncologyOncogenesBone TumorsMalignant NeoplasmsMalignant TumorsPrimary Bone SarcomasAdult Bone SarcomasAntiproliferative AgentsAtmospheric Pressure Plasma TreatmentBone Tumor PrognosisCell Growth MonitoringCold Plasma TreatmentMembrane Permeability EnhancementPlasma Treatment
Chondrosarcoma is the second most common malign bone tumor in adults. Surgical resection of the tumor is recommended because of its resistance to clinical treatment such as chemotherapy and radiation therapy. Thus, the prognosis for patients mainly depends on sufficient surgical resection. Due to this, research on alternative therapies is needed. Cold atmospheric plasma (CAP) is an ionized gas that contains various reactive species. Previous studies have shown an anti-oncogenic potential of CAP on different cancer cell types. The current study examined the effects of treatment with CAP on two chondrosarcoma cell lines (CAL-78, SW1353). Through proliferation assay, the cell growth after CAP-treatment was determined. A strong antiproliferative effect for both cell lines was detected. By fluorescein diacetate (FDA) assay and ATP release assay, alterations in the cell membrane and associated translocation of low molecular weight particles through the cytoplasmic membrane were observed. In supernatant, the non-membrane-permeable FDA and endogenously synthesized ATP detected suggest an increased membrane permeability after CAP treatment. Similar results were shown by the dextran-uptake assay. Furthermore, fluorescence microscopic G-/F-actin assay was performed. G- and F-actin were selectively dyed, and the ratio was measured. The presented results indicate CAP-induced changes in cell membrane function and possible alterations in actin-cytoskeleton, which may contribute to the antiproliferative effects of CAP.
40
Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy
Michael Keidar, Ryan M. Walk, Alexey Shashurin et al. · British Journal of Cancer · 2011 · 755 citations · Full text
Medicine, Cancer Biology, Oncology +17
ROS implication in a new antitumor strategy based on non‐thermal plasma
Marc Vandamme, Éric Robert, Stéphanie Lerondel et al. · International Journal of Cancer · 2011 · 595 citations · Full text
Medicine, Cancer Biology, Oncology +14
Effects of Non-Thermal Plasma on Mammalian Cells
Sameer Kalghatgi, Crystal Kelly, Ekaterina Cerchar et al. · PLoS ONE · 2011 · 508 citations · Full text
Suresh G. Joshi, Moogega Cooper, Adam Yost et al. · Antimicrobial Agents and Chemotherapy · 2011 · 507 citations